SCHEMBL42481

SCHEMBL42481

O=C1c2ccccc2C(=O)c2c(Nc3cccc4c3C(=O)c3ccccc3C4=O)cccc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.71
MAPK1 P28482 6/20 0.71
L3MBTL1 Q9Y468 5/20 0.71
EGFR P00533 4/20 0.71
SMN1; SMN2 Q16637 4/20 0.71
TDP1 Q9NUW8 2/20 0.71
PABPC1 P11940 1/20 0.71
RAB9A P51151 1/20 0.71
CYP1A2 P05177 3/20 0.68
MAOA P21397 4/20 0.62
GNG2 P59768 1/20 0.62
GNB1 P62873 1/20 0.62
HIF1A Q16665 1/20 0.62
ADORA2A P29274 1/20 0.55
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
CDC25B P30305 1/20 0.52
ALDH1A1 P00352 7/20 0.50
LMNA P02545 2/20 0.50
RECQL P46063 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11306687 1.00 MAPT (0.71) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL29438168 1.00 MAPT (0.71) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL10601717 0.96 CYP1A2 (0.69) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL11058968 0.89 MAPK1 (0.59) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL8606497 0.89 MAPT (0.64) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL625150 0.88 MAPT (0.62) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL11331367 0.88 CYP1A2 (0.64) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL11167085 0.87 MAPT (0.71) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL8673307 0.87 MAPT (0.61) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2
SCHEMBL11600205 0.85 MAPT (0.59) MAPTMAPK1L3MBTL1EGFRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212935-A1 ANTHRAQUINONE DYES AS PHOTOSENSITIZERS IN PHOTOVOLTAIC CELLS Clariant Finance (BVI) Limited (VG) 2010-08-04 EP claimed
WO-2009063020-A1 ANTHRAQUINONE DYES AS PHOTOSENSITIZERS IN PHOTOVOLTAIC CELLS CLARIANT INTERNATIONAL LTD (CH) 2009-05-22 WO claimed
US-6986795-B2 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing L'OREAL (FR) 2006-01-17 US claimed
US-20040074016-A1 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing L'OREAL S.A 2004-04-22 US claimed
US-6554872-B2 Direct dyes; hair dyes L'OREAL S.A. (FR) 2003-04-29 US claimed
EP-1006153-B1 Cationic amino-dianthraquinones, use thereof, dyeing compositions containing them and dyeing processes OREAL (FR) 2003-02-12 EP claimed
US-20010049848-A1 CATIONIC AMINODIANTHRAQUINONES, USE, DYEING COMPOSITIONS CONTAINING THEM AND METHODS OF DYEING L'OREAL S.A. (FR) 2001-12-13 US claimed
US-5352748-A Coating of antraquinone dye and reducing agent in alkaline solution; emulsion/suspension/bulk/solution and gas phase polymerization of ethylenically unsaturated compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 1994-10-04 US claimed
EP-0525073-B1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA DU PONT (US) 1994-05-25 EP claimed
EP-0557121-A2 Polymer scale preventive agent Shin-Etsu Chemical Co., Ltd. (JP) 1993-08-25 EP claimed
EP-0210955-A2 Process for the preparation of anthrimide carbazoles CIBA-GEIGY AG (CH) 1987-02-04 EP claimed
EP-0090278-B1 PROCESS FOR THE PREPARATION OF ANTHRIMIDE CARBAZOLE DYES BAYER AG (DE) 1985-11-27 EP claimed
EP-0084315-B1 ANTHRAQUINONE VAT DYES BAYER AG (DE) 1985-09-25 EP claimed
EP-0151552-A1 Process for the continuous dyeing of cellulosic/polyamide blended fabrics CIBA-GEIGY AG (CH) 1985-08-14 EP claimed
EP-0049873-B1 PROCESS FOR THE CARBAZOLATION OF ANTHRIMIDES CIBA-GEIGY AG (CH) 1985-01-16 EP claimed
EP-0047205-B1 PROCESS FOR THE PREPARATION OF ALPHA-BENZAMIDO-ALPHA'-HALOGEN-1,1'-DIANTHRIMIDES, ALPHA-BENZAMIDO-5' OR 8'-HALOGEN-1,1'-DIANTHRIMIDES AND THEIR APPLICATION AS INTERMEDIATES FOR VAT DYES I.C.I. FRANCOLOR S.A. (FR) 1984-04-25 EP claimed
US-4382034-A Process for the preparation of dianthraquinonylamines BAYER AKTIENGESELLSCHAFT (DE) 1983-05-03 US claimed
US-4349478-A Process for the carbazolation of anthrimides CIBA-GEIGY AG (CH) 1982-09-14 US claimed
EP-0047205-A2 Process for the preparation of alpha-benzamido-alpha'-halogen-1,1'-dianthrimides, alpha-benzamido-5' or 8'-halogen-1,1'-dianthrimides and their application as intermediates for vat dyes I.C.I. FRANCOLOR S.A. (FR) 1982-03-10 EP claimed
US-4284770-A DEHALOGENATION, HYDRAZINE COMPOUND CIBA-GEIGY CORPORATION (US) 1981-08-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049848-A1 CATIONIC AMINODIANTHRAQUINONES, USE, DYEING COMPOSITIONS CONTAINING THEM AND METHODS OF DYEING KRT18, AAAS, AADAT MAPT 1961/4885MAPK1 4075/4885L3MBTL1 4650/4885
US-20040074016-A1 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing KRT18, AAAS, AADAT MAPT 1961/4885MAPK1 4075/4885L3MBTL1 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.